Heartbeam

BEAT · NASDAQ

$0.4108−$0.0022 (−0.53%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $0.413

Latest news

Press releaseOct 15, 8:31 AM ETBusiness Wire
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
NewsOct 5, 1:46 PM ETVandana Singh
HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
NewsOct 5, 12:43 PM ETAvi Kapoor
Dow Gains 100 Points; ISM Services PMI Falls In September
Press releaseOct 5, 10:39 AM ETGlobe Newswire
Commercial Orders, FDA Firepower and Crypto Momentum
NewsOct 5, 9:43 AM ETAvi Kapoor
US Stocks Mixed; Nasdaq Gains Over 50 Points
NewsOct 5, 8:35 AM ET
HeartBeam Receives FDA Breakthrough Device Designation For Its HeartBeam System For Assessing Potential Heart Attacks At Home
Press releaseOct 5, 8:31 AM ETBusiness Wire
HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
Press releaseSep 21, 8:31 AM ETBusiness Wire
HeartBeam, Inc. Letter to Shareholders
NewsAug 14, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 13, 5:35 PM ET
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript
Press releaseAug 13, 4:01 PM ETBusiness Wire
HeartBeam Reports Second Quarter 2026 Results
Press releaseJul 30, 7:00 AM ETBusiness Wire
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
Press releaseJul 14, 7:00 AM ETBusiness Wire
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Press releaseJun 30, 7:00 AM ETBusiness Wire
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
Press releaseJun 24, 4:05 PM ETBusiness Wire
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
Press releaseJun 2, 7:00 AM ETBusiness Wire
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
NewsMay 13, 5:35 PM ET
HeartBeam Q1 2026 Earnings Call: Complete Transcript
Press releaseMay 13, 4:01 PM ETBusiness Wire
HeartBeam Reports First Quarter 2026 Results
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
Press releaseMay 11, 8:31 AM ETBusiness Wire
HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
Press releaseMay 7, 8:31 AM ETBusiness Wire
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
Press releaseApr 30, 8:31 AM ETBusiness Wire
HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time
Press releaseApr 16, 4:05 PM ETBusiness Wire
HeartBeam Announces Closing of $10 Million Public Offering of Common Stock
NewsApr 15, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseApr 14, 10:00 PM ETBusiness Wire
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock
Press releaseApr 14, 4:05 PM ETBusiness Wire
HeartBeam Announces Proposed Public Offering of Common Stock
Press releaseMar 27, 9:30 AM ETPRNewswire
How Decentralized AI is Unlocking Value in Cardiac Diagnostics
Press releaseMar 12, 4:01 PM ETBusiness Wire
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
NewsMar 12, 7:11 AM ET
Earnings Scheduled For March 12, 2026
NewsMar 10, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseMar 10, 7:00 AM ETBusiness Wire
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
Press releaseMar 9, 7:00 AM ETBusiness Wire
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
Press releaseMar 5, 7:00 AM ETBusiness Wire
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
Press releaseMar 4, 4:01 PM ETBusiness Wire
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
Press releaseMar 4, 7:00 AM ETBusiness Wire
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market
Press releaseJan 22, 7:00 AM ETBusiness Wire
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
NewsDec 22, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsDec 11, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsDec 10, 11:27 AM ETVandana Singh
Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System

Dow Gains 100 Points; ISM Services PMI Falls In September

Commercial Orders, FDA Firepower and Crypto Momentum

US Stocks Mixed; Nasdaq Gains Over 50 Points

HeartBeam Receives FDA Breakthrough Device Designation For Its HeartBeam System For Assessing Potential Heart Attacks At Home

HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

HeartBeam, Inc. Letter to Shareholders

12 Health Care Stocks Moving In Friday's Intraday Session

HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript

HeartBeam Reports Second Quarter 2026 Results

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Reports First Quarter 2026 Results

Earnings Scheduled For May 13, 2026

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

12 Health Care Stocks Moving In Wednesday's Intraday Session

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

HeartBeam Announces Proposed Public Offering of Common Stock

How Decentralized AI is Unlocking Value in Cardiac Diagnostics

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Earnings Scheduled For March 12, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Why Is Micro Cap HeartBeam Stock Surging On Wednesday?